OVX-033

N/A

Report date: 2024/06/26 15:58:44

Base Information

Drug NameOVX-033
Drug Alias NameOVX033OVX-033
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Severe Acute Respiratory Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOsivax Sas
China Registration ClassN/A

Develop Information

Active CompaniesOsivax Sas
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Severe Acute Respiratory Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A